Torben Kimhofer
Murdoch University(AU)Avenir Health(US)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Liver Disease Diagnosis and Treatment, Long-Term Effects of COVID-19, Hepatitis C virus research, Intensive Care Unit Cognitive Disorders
Most-Cited Works
- → Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection(2020)188 cited
- → Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome(2021)120 cited
- → Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review(2015)118 cited
- → Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses(2021)108 cited
- → NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines(2021)82 cited
- → Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)(2016)73 cited
- → Diffusion and Relaxation Edited Proton NMR Spectroscopy of Plasma Reveals a High-Fidelity Supramolecular Biomarker Signature of SARS-CoV-2 Infection(2021)65 cited
- → Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artifact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples(2020)60 cited
- → Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts(2021)48 cited
- → Urinary metabolic phenotyping for Alzheimer’s disease(2020)47 cited